Clinical Trials Directory

Trials / Unknown

UnknownNCT03941990

Lumbar Puncture in Emergency Under Nitrous OXide

Impact of 50% Nitrous Oxide Inhalation on Pain Induced by Lumbar Puncture in Emergency: a Double-blind Randomized Controlled Trial.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
88 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Lumbar puncture (LP) is a frequent exam that can cause pain and anxiety. In a scheduled setting, it has been shown that nitrous oxide use during the procedure was able to reduce both pain and anxiety. The goal of this trial is to confirm these results in a more heterogeneous group of patients having a LP, in an emergency setting.

Detailed description

Nitrous oxide (N2O) has analgesic and anxiolytic properties that are known for more than a century. Nonetheless, it's use during lumbar puncture in adults has only been investigated in a scheduled setting.Thus, this study is designed to evaluate the analgesic effect of N2O on the pain induced during lumbar puncture. Patients with urgent lumbar puncture realized for diagnosis purposes will be randomized in 2 groups. One group will inhale N2O for the 5 minutes before the puncture and during the rest of the procedure. The second group will inhale compressed air during the same period. Neither the investigator realizing the lumbar puncture, nor the patient will know which type of gaz they are inhaling (double-blinding). The maximal pain level that occurred during the procedure will be evaluated on a Numerical Rating Scale (NRS). NRS will also be used to evaluate the maximal anxiety induced by the procedure.

Conditions

Interventions

TypeNameDescription
DRUGFixed 50:50 mixture of nitrous oxide and oxygenGaz inhalation will start 5 minutes before the puncture and will be continued until the end of the procedure.
OTHERPlaceboinhale medical air (22% O2 - 78% N2)

Timeline

Start date
2019-11-27
Primary completion
2020-04-01
Completion
2020-09-01
First posted
2019-05-08
Last updated
2020-02-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03941990. Inclusion in this directory is not an endorsement.